Your browser doesn't support javascript.
loading
Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring.
Nagy, Dóra; Verheyen, Sarah; Wigby, Kristen M; Borovikov, Artem; Sharkov, Artem; Slegesky, Valerie; Larson, Austin; Fagerberg, Christina; Brasch-Andersen, Charlotte; Kibæk, Maria; Bader, Ingrid; Hernan, Rebecca; High, Frances A; Chung, Wendy K; Schieving, Jolanda H; Behunova, Jana; Smogavec, Mateja; Laccone, Franco; Witsch-Baumgartner, Martina; Zobel, Joachim; Duba, Hans-Christoph; Weis, Denisa.
Afiliación
  • Nagy D; Institute of Medical Genetics, Kepler University Hospital Med Campus IV, Johannes Kepler University Linz, A-4020 Linz, Austria.
  • Verheyen S; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, 8010 Graz, Austria.
  • Wigby KM; Department of Pediatrics, University of California, San Diego, CA 92161, USA.
  • Borovikov A; Rady Children's Hospital-San Diego, Rady Children's Institute for Genomic Medicine, San Diego, CA 92123, USA.
  • Sharkov A; Research Centre for Medical Genetics, 115478 Moscow, Russia.
  • Slegesky V; Veltischev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical University, 125412 Moscow, Russia.
  • Larson A; Department of Pediatrics, Section of Clinical Genetics and Metabolism, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Fagerberg C; Department of Pediatrics, Section of Clinical Genetics and Metabolism, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO 80045, USA.
  • Brasch-Andersen C; Department of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark.
  • Kibæk M; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, 5000 Odense, Denmark.
  • Bader I; Department of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark.
  • Hernan R; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, 5000 Odense, Denmark.
  • High FA; H C Andersen Children's Hospital, Odense University Hospital, 5000 Odense, Denmark.
  • Chung WK; Institute of Human Genetics, University Hospital, Salzburger Landeskliniken and Paracelsus Medical University Salzburg, A-5020 Salzburg, Austria.
  • Schieving JH; Department of Pediatrics, Columbia University, Irving Medical Center, New York, NY 10032, USA.
  • Behunova J; Division of Genetics, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Smogavec M; Department of Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
  • Laccone F; Department of Pediatrics and Medicine, Columbia University, New York, NY 10032, USA.
  • Witsch-Baumgartner M; Department of Pediatric Neurology, Radboud University Hospital Nijmegen, 6525 Nijmegen, The Netherlands.
  • Zobel J; Institute of Medical Genetics, Medical University of Vienna, 1090 Vienna, Austria.
  • Duba HC; Institute of Medical Genetics, Medical University of Vienna, 1090 Vienna, Austria.
  • Weis D; Institute of Medical Genetics, Medical University of Vienna, 1090 Vienna, Austria.
Genes (Basel) ; 13(1)2022 01 15.
Article en En | MEDLINE | ID: mdl-35052493
POGZ-related disorders (also known as White-Sutton syndrome) encompass a wide range of neurocognitive abnormalities and other accompanying anomalies. Disease severity varies widely among POGZ patients and studies investigating genotype-phenotype association are scarce. Therefore, our aim was to collect data on previously unreported POGZ patients and perform a large-scale phenotype-genotype comparison from published data. Overall, 117 POGZ patients' genotype and phenotype data were included in the analysis, including 12 novel patients. A severity scoring system was developed for the comparison. Mild and severe phenotypes were compared with the types and location of the variants and the predicted presence or absence of nonsense-mediated RNA decay (NMD). Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p < 0.0001). Within this group, variants in the prolin-rich region of the POGZ protein were associated with the most severe phenotypes (p = 0.0004). Our study suggests that gain-of-function or dominant negative effect through escaping NMD and the location of the variants in the prolin-rich domain of the protein may play an important role in the severity of manifestations of POGZ-associated neurodevelopmental disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transposasas / Estudios de Asociación Genética / Trastornos del Neurodesarrollo / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Genes (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transposasas / Estudios de Asociación Genética / Trastornos del Neurodesarrollo / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Genes (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Austria